Diabetes Care, Vol 21, Issue 8 1345-1348, Copyright © 1998 by American Diabetes Association
Long-term lisinopril therapy reduces exercise-induced albuminuria in normoalbuminuric normotensive IDDM patients
JA Tuominen, P Ebeling and VA Koivisto
Department of Medicine, Helsinki University Central Hospital, Finland. juha.tuominen@iki.fi
OBJECTIVE: To study the effect of lisinopril on the exercise-induced
urinary albumin excretion rate. RESEARCH DESIGN AND METHODS: A total of 26
IDDM patients with normoalbuminuria were randomized into two groups, with
one group receiving placebo (n = 13, age 36 +/- 3 years, BMI 24.5 +/- 1.1
kg/m2) and the other group receiving an average of 15 mg lisinopril daily
(n = 13, age 34 +/- 2 years, BMI 24.4 +/- 0.9 kg/m2). Overnight and
exercise-induced urinary albumin excretion rate was measured at baseline
and after 1 and 2 years of treatment. Two patients in the placebo group and
none in the lisinopril group developed microalbuminuria. RESULTS: In the
lisinopril group, the exercise-induced urinary albumin excretion rate
diminished 46% after the 1st year (P = 0.059) and 66% (P < 0.01) after
the 2nd year. However, it remained unchanged in the control group. Systolic
blood pressure (sBP) and diastolic blood pressure (dBP) were similar at
baseline and after 1 year, but at 2 years, sBP was 13 mmHg lower (P = 0.03)
and dBP was 9 mmHg lower (P = 0.052) in the lisinopril group as compared
with the control group. The dBP decreased significantly at 1 and 2 years in
the lisinopril group, while there was no significant change in the sBP. In
the whole group at baseline, the overnight albumin excretion rate
correlated with HbA1c (r = 0.50, P < 0.01) and the duration of diabetes
(r = 0.39, P < 0.05), and sBP correlated with both the overnight (r =
0.42, P < 0.05) and the exercise-induced (r = 0.48, P < 0.05) albumin
excretion rate. CONCLUSIONS: Glycemic control and blood pressure are
directly related to the overnight albumin excretion rate also in
normotensive normoalbuminuric IDDM patients. Lisinopril treatment reduces
the exercise-induced urinary albumin excretion rate in such patients. These
data suggest a protective effect of lisinopril against the development of
microalbuminuria.